WAVE Life Sciences (WVE) Tops Q4 EPS by 8c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St slips as higher Treasury yields weigh on sentiment
- Oil pares losses as market weighs Saudi supply concerns, Middle East tensions
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
RBC Capital on WAVE Life Sciences (WVE): 'We appreciate the progress but remain cautious'
March 6, 2024 4:18 PM ESTRBC Capital analyst Luca Issi reiterated a Sector Perform rating and $5.00 price target on WAVE Life Sciences (NASDAQ: WVE).
The analyst comments "Next data is HD in Q2 and 20% allele specific KD is the bogey for a go/no-go decision and TAK... More
